secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2022-04-28T23:59:59+00:00
Accession:  0000950170-22-006426
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mednax Q1 GAAP loss $0.25/sh includes $57M debt charge; adj EPS $0.33
---------------------------------------------------------------------

- Revenue $482M (+8% YoY); same-unit revenue +1.3%, volume +3.2%.
- GAAP loss from continuing ops $20.9M ($0.25/sh) vs income $5.4M ($0.06/sh) prior year.
- Adjusted EPS $0.33 vs $0.24 prior year; Adjusted EBITDA $50.7M vs $45.5M.
- Issued $400M 5.375% notes due 2030; redeemed $1.0B 6.25% notes due 2027, causing $57M loss.
- Cash from ops used $89.9M; total debt $799M at quarter end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017022006426/0000950170-22-006426-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017022006426/md-20220428.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-006426

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer